Release Date: January 24, 2025
For the complete transcript of the earnings call, please refer to the full earnings call transcript.
Q: Can you discuss Moog's involvement in Collaborative Combat Aircraft (CCA) programs and how it compares to other large programs like FLRAA or F-35? A: We are engaged in several CCA programs, focusing on proving our concepts in the early stages. Our role as a mechanical component supplier, particularly in flight control, is valuable. Currently, our involvement is with one or two platforms, not all players.
Q: Regarding Boeing's investment in the 787 production line, how does this impact their capacity and future production rates? A: Boeing aims to achieve a production rate of 10 for the 787 wide-body aircraft by fiscal '26, with their investment in the Charleston facility supporting this goal.
Q: How did Moog manage to drive aftermarket orders in the commercial space despite the Tewkesbury facility being down? A: Our repair work is distributed across multiple facilities globally, allowing us to maintain a strong aftermarket business. We also provisioned airlines with spares to ensure fleet readiness, contributing to the sales boost.
Q: Why didn't Moog adjust out the warranty expense, and is the 14.4% margin sustainable? A: The warranty expense is a one-time adjustment, not reflective of ongoing operations. The strong aftermarket performance drove the high margin, but we don't expect the same level of provisioning to repeat in subsequent quarters.
Q: Can you provide insights into the industrial segment's bookings and market conditions? A: The industrial automation business is stable, with a book-to-bill ratio greater than 1. While the German economy's softness affects orders, our medical pumps business reached record sales, offsetting some declines.
Q: What factors contribute to the second-quarter earnings guidance being sequentially down from the first quarter? A: The guidance reflects a similar operating margin to Q1, excluding the out-of-period warranty expense and extraordinary commercial aftermarket strength seen in Q1.
Q: How does Moog plan to achieve its free cash flow conversion guidance after burning $165 million in Q1? A: Improvements in Q2 will come from better inventory management, compensation payment timing, and defense advances. Significant cash generation is expected in the second half of the year through operational performance and receivables collection.
Q: What is the outlook for Moog's medical device business, given the competitor's challenges? A: We expect to maintain the market share gained due to competitor issues, as our products are relatively sticky once deployed. The impact is expected to last six to nine months.
For the complete transcript of the earnings call, please refer to the full earnings call transcript.
This article first appeared on GuruFocus.免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。